Specific gut bacteria predict cancer immunotherapy response
News-Medical.Net — March 2, 2024, 04:00 AM UTC
Summary: A study published in Nature Medicine on 1 March reveals that specific gut bacteria strains can predict positive responses to combination immunotherapy in cancer patients. The research, conducted by the Wellcome Sanger Institute and the Olivia Newton-John Cancer Research Institute, identified a microbiome signature that can be used to develop personalized cancer treatments. The study used samples from a large Australian clinical trial and found that the microbiome impacts treatment response.
Article metrics
The article metrics are deprecated.
I'm replacing the original 8-factor scoring system with a new and improved one. It doesn't use the original factors and gives much better significance scores.